“Game-changing” obesity drug over-promising?
World of DTC Marketing
NOVEMBER 5, 2021
Novo Nordisk has admitted that it would not be able to keep up, adding that it would likely take until early 2022 for the supply to stabilize and that some patients “are experiencing an approximate one month or longer delay in filling prescriptions for Wegovy.” Many factors contribute to obesity.
Let's personalize your content